OMV AG/ AT0000743059 /
24/01/2025 17:35:27 | Chg. -0.060 | Volume | Bid24/01/2025 | Ask24/01/2025 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
39.160EUR | -0.15% | 209,717 Turnover: 8.21 mill. |
-Bid Size: - | -Ask Size: - | 12.8 bill.EUR | 12.90% | 8.64 |
GlobeNewswire
26/03/2024
Intravacc announces positive data of first in human intranasal OMV based vaccine for SARS-CoV-2
GlobeNewswire
16/01/2024
Intravacc Awarded US$ 633K CARB-X Funding to Develop a Vaccine that Prevents Gonorrhea Infections
GlobeNewswire
14/09/2023
Intravacc Announces Review Publication of OMV-based Intranasal Vaccines for Disease Prevention
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center
GlobeNewswire
04/12/2018
CGG and OMV: Continue Cooperation with Multi-Year Extension of Dedicated Center